Merck & Co., Inc.

128 Sidney Street
- Cambridge,  MA  02139

United States
https://acceleronpharma.com/
  • Booth: 2700

Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our strategy is to develop medicines that selectively target multiple ligands (proteins) in the TGF-beta superfamily, which play critical roles in the development of serious diseases. Our deep scientific leadership in this area of biology has enabled us to focus our research, development, and commercialization efforts in pulmonary and hematologic diseases.


 Additional Info

ACC.22 Learning Pathways? (select all that apply)
Pulmonary Vascular Disease